As the therapeutic landscape for advanced and metastatic urothelial carcinoma (mUC) rapidly evolves, staying updated on the latest guidelines, new approvals, and clinical data is crucial for optimizing patient outcomes. In this on-demand video featuring experts in bladder cancer, tune in for a discussion on differentiating treatment options based on the latest efficacy and safety data, and strategies to individualize treatment plans, manage adverse events, and improve patient adherence to therapies. Real-world case discussions will highlight how to align guideline-based recommendations with patient goals and preferences, and enhance collaborative, shared decision-making for improved patient-centered care. This activity is delivered in partnership with Cancer Care.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/improving-individualized-care-advanced-metastatic-bladder-cancer
- Start Date: 2024-11-04 06:00:00
- End Date: 2024-11-04 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Gilead Sciences, Inc. - Amount: 36250.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology